Negative Pressure Wound Therapy Market by Product (Conventional, Single-use NPWT, Consumables, Accessories), Wound Type (Burns, Surgical, Traumatic, Diabetic Foot, Pressure, Venous Leg Ulcers), End User (Hospitals, Homecare) - Global Forecast to 2030

icon1
USD 3.84 BN
MARKET SIZE, 2030
icon2
CAGR 6.9%
(2025-2030)
icon3
249
REPORT PAGES
icon4
233
MARKET TABLES

OVERVIEW

Negative Pressure Wound Therapy Market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The global negative pressure wound therapy market is projected to reach USD 3.84 billion by 2030 from USD 2.76 billion in 2025, at a CAGR of 6.9% during the forecast period. The increasing prevalence of diabetes, rising cases of traumatic injuries and burn injuries and growing geriatric population drives market growth. Rise in the chronic wound numbers has also facilitated the market. Additionally, favorable government and industry initiatives and reimbursement scene are expected to impact market growth. The growth potential of emerging countries and cost effectiveness of negative pressure wound therapy products also poses an opportunistic factor for market growth.

KEY TAKEAWAYS

  • BY PRODUCT TYPE
    The negative pressure wound therapy market is divided into conventional NPWT devices, single-use NPWT devices, and NPWT accessories and consumables based on product type. In a recent year, conventional NPWT devices held the largest share of this market. A key advantage of these devices is their capacity to provide consistent, adjustable pressure levels and continuous therapy, allowing treatments to be customized to each patient's unique needs. These devices also feature larger canisters for handling high-exudate wounds, aiding in long-term wound care. This makes them valuable in hospital and intensive care settings where close monitoring by healthcare professionals is essential. Additionally, the widespread clinical evidence supporting their use, including reports and studies, highlights that conventional NPWT systems can speed up healing, lower infection risks, and enhance patient recovery, especially in severe or chronic wounds. This proven track record has earned strong clinician confidence and established their ongoing use as a standard care practice in numerous hospitals.
  • BY WOUND TYPE
    Based on wound type, the burns and surgical & open wounds segment held the largest share of the negative pressure wound therapy market in a recent year. This is attributed to their frequency and complexity, which require advanced wound management solutions. NPWT devices facilitate faster healing, reduce infection risk, and enhance tissue regeneration. Surgical wounds, in particular, benefit significantly from the ability of NPWT devices to maintain a clean, moist wound environment and minimize edema.
  • BY END USER
    Based on end user, the negative pressure wound therapy market is categorized into home care settings, hospitals, and other end users. Among these, hospitals lead with the largest market share in a recent year. The demand for negative pressure wound therapy products in hospitals has been further boosted by the increasing occurrence of pressure ulcers, traumatic wounds, and post-operative wounds. Hospital visits for wound care have also risen due to the growing number of older individuals with chronic conditions such as diabetes and vascular diseases, including diabetic foot ulcers. Hospitals and clinics are equipped to treat wounds efficiently thanks to established wound care protocols, skilled medical staff, and a diverse selection of NPWT products. They also provide close monitoring of patients using conventional NPWT devices. As a result of the heightened emphasis on enhancing wound care practices and patient recovery outcomes, this market segment maintains its leading position.
  • BY REGION
    The global negative pressure wound therapy market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Asia Pacific is witnessing strong growth due to its aging population, inceasing healthcare costs, and a rising prevalnce of chronic wound.
  • COMPETITIVE LANDSCAPE
    The global negative pressure wound therapy market is steadily growing, driven by strategic partnerships and strong R&D investments. Key players like Solventum (US), Smith+ Nephew (UK), Cardinal health (US), Mölnlycke AB (Sweden), Convatec Group PLC (UK), and others leverage diverse product portfolios and innovation to expand globally through collaborations, acquisitions, and new product launches.

The global negative pressure wound therapy market is expected to grow significantly by the end of the forecast period, starting from its value in 2025, with a steady compound annual growth rate. The rising prevalence of diabetes, increasing instances of traumatic injuries and burns, and an aging population are key drivers of market expansion. The increase in chronic wound cases has also contributed to this growth. Additionally, supportive government and industry efforts, along with a favorable reimbursement environment, are anticipated to influence market development. The potential in emerging countries and the cost-effectiveness of negative pressure wound therapy products are also seen as promising factors for market growth.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The impact on the negative wound pressure therapy market stems from evolving healthcare needs and advancements in wound care solutions. Hospitals, home care settings, and other end users form the core customer base, addressing verious wound types such as surgical & open wounds, diabetic foot ulcers, venous leg ulcers. Additionally, the focus on reducing complications through innovative treatments is fueling the demand for NPWT products. These trends shape customer decisions and attract investments in innovative solutions.

Negative Pressure Wound Therapy Market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Increasing cases of traumatic injuries
  • Favorable government and industry initiatives and reimbursement policies
RESTRAINTS
Impact
Level
  • High cost of negative pressure wound therapy devices
  • Risks associated with use of negative pressure wound therapy products
OPPORTUNITIES
Impact
Level
  • Growing usage of simplified single-use devices
  • Increasing use of simplified single-use devices
CHALLENGES
Impact
Level
  • Availability of alternative therapies
  • Limited awareness among healthcare providers

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver:Increasing cases of traumatic injuries

Growing number of road accidents has led to traumatic injuries that need negative pressure wound care products. These issues slow down the healing process and increase the risk of tissue damage. According to a report from January 2022 by NCBI, Brazil has about 40,000 road traffic deaths every year, making it one of the top five countries for traffic-related fatalities.These severe accidents leads to traumatic injuries that often require advanced treatments and targeted wound care products like negative pressure wound therapy devices that are vital for keeping wounds in a controlled environment and helping them heal faster compared to other solutions for the patient. There are other countries too with high road traffic accident rates such as India, China, and the US that are also witnessing a rise in demand for NPWT products. These countries with others are investing in trauma care clinics and infrastructure and adopting advanced wound management solutions to address the rising burden of trauma related injuries. As a result, healthcare systems are increasingly incorporating NPWT devices into standard treatment protocols, further driving market growth on a global scale for the negative pressure wound therapy market.

Restraint: High cost of negative pressure wound therapy devices

The high cost of chronic wound solutions and negative pressure wound therapy products can be a restrain for long-term use, especially in cost sensitive markets where the households have a low income. In these regions, patients and healthcare providers often turn to more affordable options due to budget limitations and limited insurance coverage. An article published in Advances in Wound Care found that wounds that are chronic non healing type that target around 1% to 2% of the population, treating this wound type can go up to around USD 50 million annually. Foot ulcers, particularly common among people with diabetes, affect about 25% of the diabetic population and are a leading cause of hospitalization, contributing to high healthcare costs. As awareness grows about the benefits of negative pressure wound therapy and disposable incomes rise in many countries, the adoption of these products is expected to increase.

Opportunity: Growing usage of simplified single-use devices

One of the key opportunities in the negative pressure wound therapy market is the growing use and need of simplified, single-use NPWT devices. These devices are easy to use that are built for outpatients, it offers an effective alternative to traditional, more complex NPWT machines typically used in hospitals. As the patients find ways to reduce hospital stays and manage overall expense, single-use NPWT devices provide a practical solution for patients who can carry on with their wound care treatment at home without compromising clinical outcomes.These devices are pre-set, require minimal training, and eliminate the need for regular maintenance or device returns, which is particularly beneficial in remote or resource-limited areas. These portable and convenience devices are popular for managing post-surgical wounds, diabetic foot ulcers, pressure ulcers and other chronic wounds in homecare settings. Patients also prefer them due to their advanced design, lightweight structure, and ease for mobility, which improves comfort during recovery. Medical device companies are engaging in this trend by expanding their single-use product lines and securing regulatory approvals in the negative pressure wound therapy market.

Challenge: Limited awareness among healthcare providers

In countries with lower income like Afghanistan, and African countries, many people suffer delays in getting chronic wound properly diagnosed. This is often caused due to a lack of proper medical guidance, limited access to advanced healthcare, the healthcare faculties not being up to date with the rising technologies, and low awareness about the dangers of slow healing wounds. Without receiving timely treatment, complications can be escalated to worsen the situation, making recovery more difficult and putting added strain on healthcare systems. Medical assistance may be delayed in these areas because many people may not be able to identify the early warning symptoms of wound complications. As a result, poor wound care becomes widespread, leading to longer recovery periods, a higher risk of infection, more expensive therapy, and a general deterioration in patient health. The effects might be more severe for people with long term health issues like diabetes, which can result in serious infections or amputations. Timely diagnosis and treatment can lower the burden on healthcare system in these countries, by reducing complications and improving healing. Thus, this issue requires more educational campaigns, easier access to medical treatments and adoption of standard wound care procedures.

Negative Pressure Wound Therapy Market: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Provides advanced negative pressure wound therapy systems designed to manage acute, chronic, and surgical wounds across healthcare and home settings. Promotes faster wound closure, enhances granulation tissue formation, reduces exudate and edema, and lowers the risk of infection to support effective wound healing.
Offers comprehensive negative pressure wound therapy solutions for complex wounds such as pressure injuries, diabetic ulcers, and post-operative wounds. Maintains an optimal healing environment, accelerates tissue repair, reduces dressing change frequency, and improves patient comfort and mobility.
Supplies reliable negative pressure wound therapy systems designed for both inpatient and outpatient wound management, supporting clinical efficiency and patient safety. Facilitates effective exudate removal, reduces infection risk, promotes consistent wound healing, and ensures accessibility through cost-effective care solutions.
Develops negative pressure wound therapy solutions tailored for surgical and chronic wounds, emphasizing patient safety and ease of use in diverse care environments. Minimizes wound complications, enhances tissue regeneration, reduces healing time, and improves patient outcomes through advanced exudate management.
Provides negative pressure wound therapy technologies and accessories for managing exuding, hard-to-heal, and chronic wounds in clinical and home care settings. Supports continuous wound healing, improves moisture balance, enhances patient comfort, and shortens recovery time by optimizing wound bed conditions.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The ecosystem market map of the negative pressure wound therapy industry includes its key elements, which are defined by the organizations involved. Product manufacturers of NPWT products are companies engaged in research, product development, optimization, and launching. Manufacturers of NPWT products include organizations engaged in research, product development, optimization, and launch. To get items to end users—Hospitals, homecare settings, and other healthcare facilities, who NPWT products for treatments of surgical & open wounds, pressure ulcers, diabetic foot ulcers, venous leg ulcers. Regulatory agencies monitor product safety, quality, and conformity to industry standards.

Negative Pressure Wound Therapy Market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

Negative Pressure Wound Therapy Market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Negative Pressure Wound Therapy Market, By Product

The negative pressure wound therapy market is segmented into conventional NPWT devices, single-use NPWT devices, and NPWT accessories & consumables for product type. In 2024, the conventional NPWT devices accounted for the larger share of this market. One of the main features of the conventional NPWT devices is their ability to deliver maintained customizable pressure levels and continuous therapy, this helps tailor treatment to every patient’s specific needs. These devices are also equipped with features like bigger canisters for managing high exudate wounds, which helps in the long-term wound management. This makes them useful in hospitals and intensive care settings where close monitoring by the healthcare faculties is needed.Another reason for their lead in the market is the volume of clinical evidence supporting their use. Reports and studies have noticed that conventional NPWT systems can reduce healing time, reduce infection risk, and improve patient recovery, particularly in severe or chronic wounds. This track record has built strong clinician trust and led to their continued use as a standard of care in many hospitals.

Negative Pressure Wound Therapy Market, By Wound Type

Based on wound type, the burns and surgical & open wounds segment accounted for the largest share in the negative pressure wound therapy market in 2024. This is due to their rising occurrence and complexity, which require advanced wound management solutions. NPWT devices promote quicker healing, reduce infection risk, and improve tissue regeneration. Surgical wounds that involve large incisions or at risk of dehiscence benefit significantly from the ability of NPWT devices to maintain a clean, moist wound environment and reduce edema.

Negative Pressure Wound Therapy Market, By End User

Based on end user, the negative pressure wound therapy market is divided into home care settings, hospitals, and other end users. Among these, hospitals hold the largest market share in 2024. The need for negative pressure wound therapy products in hospital has been further stimulated by the rising incidence of pressure ulcers, traumatic wounds and post operative wounds. Hospital visits for wound care have also increased as a result of the growing number of elderly population with chronic illnesses including diabetes and vascular diseases such as diabetes and foot ulcers. Hospitals and clinics can treat wounds quickly and effectively due to established wound care protocols, knowledgeable medical staff, and a wide range of NPWT products. They can observe the patients closely for the conventional NPWT devices. As a result of the increased focus on improving wound care practices and patient recovery rates, this market segment continues to hold its dominant position.

REGION

Asia Pacific is the fastest growing region in the negative pressure wound therapy market

Asia Pacific is emerging as the fastest-growing region in the negative pressure wound therapy market, driven by a combination of demographic, economic, and healthcare system advancements. The region is witnessing a sharp rise in the prevalence of chronic wounds, fueled by aging populations and changing lifestyles which leads do wound injuries like diabetic foot ulcers. Expanding healthcare infrastructure, growing availability of specialized wound care, and increasing adoption of NPWT are further accelerating market growth. Governments across several Asia Pacific countries are boosting investments in healthcare and supporting regulatory reforms that encourage the introduction of innovative solutions. Additionally, rising disposable incomes, improving insurance coverage, and growing awareness among patients and clinicians are contributing to higher treatment uptake. Global manufacturers are also expanding their presence through partnerships, training programs, and localized manufacturing to tap into the region’s vast, underserved patient base, positioning Asia Pacific as a key growth engine for the NPWT industry.

Negative Pressure Wound Therapy Market Region

Negative Pressure Wound Therapy Market: COMPANY EVALUATION MATRIX

Solventum split from 3M in April 2024 and established itself. It develops, manufactures, and sells a range of products to meet the needs of clients and patients. For the further expansion of the segments: MedSurg, Purification & Filtration, Dental Solutions, and Health Information Systems, the company is focusing on strategic expansion and innovation. By strengthening its competitive edge through the incorporation of digital skills and material science, the company improves clinical and financial outcomes for healthcare providers.

Negative Pressure Wound Therapy Market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET SCOPE

REPORT METRIC DETAILS
Market Size Value in 2024 USD 2.59 Billion
Revenue Forecast in 2030 USD 3.84 Billion
Growth Rate CAGR of 6.9% from 2025-2030
Actual data 2023-2030
Base year 2024
Forecast period 2025-2030
Units considered Value (USD Million), Volume (USD Thousands)
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
Segments Covered
  • Product Type ( conventional NPWT devices, single-use NPWT devices, and NPWT accessories & consumables)
  • Wound Type (burns and surgical & open wounds, pressure ulcers, diabetic foot ulcers, venous leg ulcers, and traumatic wounds)
  • End User (home care settings, hospitals, and other end users)
Regional Scope North America, Europe, Asia Pacific, Latin America and the Middle East & Africa

WHAT IS IN IT FOR YOU: Negative Pressure Wound Therapy Market REPORT CONTENT GUIDE

Negative Pressure Wound Therapy Market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Product Analysis Product Matrix, which provide a detailed comparison of the product portfolio of each company in the market. •        Enables identification of treatment adoption shifts across hospitals, home care settings and other end users; highlights efficiency, and compliance trends influencing purchasing decisions.
Company Information •        Detailed analysis and profiling of additional market players (Up to five) •        Provides insights into competitive strategies, innovation focus , and partnerships shaping the negative pressure wound therapy products and supplies landscape.
Geographic Analysis •        Further breakdown of the negative pressure wound therapy market into specific countries for the Rest of Europe, the Rest of Asia Pacific, the Rest of Latin America, and the Middle East & Africa •        Country level demand mapping for new product launches and localization strategy planning.

RECENT DEVELOPMENTS

  • April 2024 : Smith+Nephew (UK) introduced the RENASYS EDGE System designed for home care patients with chronic wounds, such as ulcers
  • March 2025 : Convatec Group PLC (UK) and the Wound, Ostomy, and Continence Nurses Society (US) collaborated to launch two free educational programs to improve ostomy care knowledge for healthcare professionals in 2025.
  • January 2025 : Cardinal Health (US) opened a distribution center in Fort Worth, Texas, to support its At-Home Solutions business
  • July 2024 : Mölnlycke AB (Sweden) and MediWound Ltd. (Israel) entered into an agreement to strengthen their partnership

 

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
26
2
RESEARCH METHODOLOGY
 
 
 
31
3
EXECUTIVE SUMMARY
 
 
 
42
4
PREMIUM INSIGHTS
 
 
 
46
5
MARKET OVERVIEW
Explore booming markets driven by aging populations and chronic disease trends, despite high therapy costs.
 
 
 
49
 
5.1
INTRODUCTION
 
 
 
 
5.2
MARKET DYNAMICS
 
 
 
 
 
5.2.1
DRIVERS
 
 
 
 
 
5.2.1.1
BOOMING GERIATRIC POPULATION
 
 
 
 
5.2.1.2
INCREASING CASES OF TRAUMATIC INJURIES
 
 
 
 
5.2.1.3
GROWING PREVALENCE OF CHRONIC DISEASES
 
 
 
 
5.2.1.4
RISING INCIDENCE OF BURN INJURIES
 
 
 
 
5.2.1.5
FAVORABLE GOVERNMENT AND INDUSTRY INITIATIVES AND REIMBURSEMENT POLICIES
 
 
 
5.2.2
RESTRAINTS
 
 
 
 
 
5.2.2.1
HIGH COST OF NEGATIVE PRESSURE WOUND THERAPY DEVICES
 
 
 
 
5.2.2.2
RISKS ASSOCIATED WITH USE OF NEGATIVE PRESSURE WOUND THERAPY PRODUCTS
 
 
 
5.2.3
OPPORTUNITIES
 
 
 
 
 
5.2.3.1
GROWTH OPPORTUNITIES IN EMERGING ECONOMIES
 
 
 
 
5.2.3.2
INCREASING USE OF SIMPLIFIED SINGLE-USE DEVICES
 
 
 
5.2.4
CHALLENGES
 
 
 
 
 
5.2.4.1
AVAILABILITY OF ALTERNATIVE THERAPIES
 
 
 
 
5.2.4.2
LIMITED AWARENESS AMONG HEALTHCARE PROVIDERS
 
 
5.3
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
 
 
 
 
5.4
PRICING ANALYSIS
 
 
 
 
 
 
5.4.1
AVERAGE SELLING PRICE TREND, BY PRODUCT
 
 
 
 
5.4.2
AVERAGE SELLING PRICE TREND, BY KEY PLAYER
 
 
 
 
5.4.3
AVERAGE SELLING PRICE TREND, BY REGION
 
 
 
5.5
VALUE CHAIN ANALYSIS
 
 
 
 
 
5.6
SUPPLY CHAIN ANALYSIS
 
 
 
 
 
5.7
ECOSYSTEM ANALYSIS
 
 
 
 
 
5.8
INVESTMENT AND FUNDING SCENARIO
 
 
 
 
5.9
TECHNOLOGY ANALYSIS
 
 
 
 
 
5.9.1
KEY TECHNOLOGIES
 
 
 
 
 
5.9.1.1
VACUUM-ASSISTED CLOSURE (VAC) THERAPY
 
 
 
5.9.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
5.9.2.1
TOPICAL OXYGEN THERAPY
 
 
 
5.9.3
ADJACENT TECHNOLOGIES
 
 
 
 
 
5.9.3.1
HYPERBARIC OXYGEN THERAPY
 
 
5.10
PATENT ANALYSIS
 
 
 
 
 
5.11
TRADE ANALYSIS
 
 
 
 
 
 
5.11.1
IMPORT DATA (HS CODE 901890)
 
 
 
 
5.11.2
EXPORT DATA (HS CODE 901890)
 
 
 
5.12
KEY CONFERENCES AND EVENTS, 2025–2026
 
 
 
 
5.13
CASE STUDY ANALYSIS
 
 
 
 
 
5.13.1
CASE STUDY 1: COMPLEX WOUND HEALING WITH TOPICAL NEGATIVE PRESSURE WOUND THERAPY
 
 
 
 
5.13.2
CASE STUDY 2: NECROTIZING FASCIITIS MANAGED WITH NEGATIVE PRESSURE WOUND THERAPY FOR BETTER WOUND CLOSURE
 
 
 
 
5.13.3
CASE STUDY 3: TREATMENT OF HARD-TO-HEAL WOUNDS WITH PORTABLE NEGATIVE PRESSURE WOUND THERAPY
 
 
 
5.14
REGULATORY LANDSCAPE
 
 
 
 
 
5.14.1
REGULATORY ANALYSIS
 
 
 
 
 
5.14.1.1
NORTH AMERICA
 
 
 
 
5.14.1.2
EUROPE
 
 
 
 
5.14.1.3
ASIA PACIFIC
 
 
 
 
5.14.1.4
LATIN AMERICA
 
 
 
 
5.14.1.5
MIDDLE EAST
 
 
 
5.14.2
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
5.14.2.1
NORTH AMERICA
 
 
 
 
5.14.2.2
EUROPE
 
 
 
 
5.14.2.3
ASIA PACIFIC
 
 
 
 
5.14.2.4
LATIN AMERICA
 
 
 
 
5.14.2.5
REST OF THE WORLD
 
 
5.15
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
5.15.1
BARGAINING POWER OF SUPPLIERS
 
 
 
 
5.15.2
BARGAINING POWER OF BUYERS
 
 
 
 
5.15.3
THREAT OF NEW ENTRANTS
 
 
 
 
5.15.4
THREAT OF SUBSTITUTES
 
 
 
 
5.15.5
INTENSITY OF COMPETITIVE RIVALRY
 
 
 
5.16
KEY STAKEHOLDERS AND BUYING CRITERIA
 
 
 
 
 
 
5.16.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
5.16.2
BUYING CRITERIA
 
 
 
5.17
IMPACT OF AI ON NEGATIVE PRESSURE WOUND THERAPY MARKET
 
 
 
 
 
 
5.17.1
INTRODUCTION
 
 
 
 
5.17.2
MARKET POTENTIAL OF AI IN NEGATIVE PRESSURE WOUND THERAPY MARKET
 
 
 
 
5.17.3
AI USE CASES
 
 
 
 
5.17.4
KEY COMPANIES IMPLEMENTING AI
 
 
 
 
5.17.5
FUTURE OF AI IN NEGATIVE PRESSURE WOUND THERAPY MARKET
 
 
 
5.18
IMPACT OF US TARIFF REGULATION ON NEGATIVE PRESSURE WOUND THERAPY MARKET
 
 
 
 
 
 
5.18.1
INTRODUCTION
 
 
 
 
5.18.2
KEY TARIFF RATES
 
 
 
 
5.18.3
PRICE IMPACT ANALYSIS
 
 
 
 
5.18.4
KEY IMPACT ON COUNTRY/REGION
 
 
 
 
 
5.18.4.1
NORTH AMERICA
 
 
 
 
5.18.4.2
EUROPE
 
 
 
 
5.18.4.3
ASIA PACIFIC
 
 
 
5.18.5
IMPACT ON END-USE INDUSTRIES
 
 
 
 
 
5.18.5.1
HOSPITALS
 
6
NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 19 Data Tables
 
 
 
86
 
6.1
INTRODUCTION
 
 
 
 
6.2
CONVENTIONAL NPWT DEVICES
 
 
 
 
 
6.2.1
RISING FOCUS ON EFFECTIVE WOUND MANAGEMENT TO EXPEDITE GROWTH
 
 
 
6.3
SINGLE-USE NPWT DEVICES
 
 
 
 
 
6.3.1
INCREASING ADOPTION OF SINGLE-USE DEVICES IN HOME HEALTHCARE TO PROMOTE GROWTH
 
 
 
6.4
NPWT ACCESSORIES & CONSUMABLES
 
 
 
 
 
6.4.1
GROWING PREVALENCE OF CHRONIC WOUNDS TO DRIVE MARKET
 
 
7
NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 28 Data Tables
 
 
 
97
 
7.1
INTRODUCTION
 
 
 
 
7.2
BURNS AND SURGICAL & OPEN WOUNDS
 
 
 
 
 
7.2.1
HIGH INCIDENCE OF BURN INJURIES IN LOW AND MIDDLE-INCOME COUNTRIES TO AID GROWTH
 
 
 
7.3
PRESSURE ULCERS
 
 
 
 
 
7.3.1
INCREASING AGING POPULATION WORLDWIDE TO AUGMENT GROWTH
 
 
 
7.4
DIABETIC FOOT ULCERS
 
 
 
 
 
7.4.1
INCREASE PREVALENCE OF DIABETES TO STIMULATE GROWTH
 
 
 
7.5
VENOUS LEG ULCERS
 
 
 
 
 
7.5.1
RISING PREVALENCE OF OBESITY TO CONTRIBUTE TO GROWTH
 
 
 
7.6
TRAUMATIC WOUNDS
 
 
 
 
 
7.6.1
GROWING INCIDENCE OF TRAUMATIC INJURIES TO BOOST MARKET
 
 
8
NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 17 Data Tables
 
 
 
114
 
8.1
INTRODUCTION
 
 
 
 
8.2
HOSPITALS
 
 
 
 
 
8.2.1
RISING NUMBER OF SURGERIES TO ACCELERATE GROWTH
 
 
 
8.3
HOME CARE SETTINGS
 
 
 
 
 
8.3.1
INCREASING HEALTHCARE EXPENDITURE TO SPEED UP GROWTH
 
 
 
8.4
OTHER END USERS
 
 
 
9
NEGATIVE PRESSURE WOUND THERAPY MARKET, BY REGION
Comprehensive coverage of 7 Regions with country-level deep-dive of 16 Countries | 83 Data Tables.
 
 
 
124
 
9.1
INTRODUCTION
 
 
 
 
9.2
NORTH AMERICA
 
 
 
 
 
9.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
 
 
 
 
9.2.2
US
 
 
 
 
 
9.2.2.1
RISING REGULATORY APPROVALS AND FAVORABLE REIMBURSEMENT POLICIES TO STIMULATE GROWTH
 
 
 
9.2.3
CANADA
 
 
 
 
 
9.2.3.1
INCREASING PREVALENCE OF DIABETES TO SUPPORT GROWTH
 
 
9.3
EUROPE
 
 
 
 
 
9.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
 
 
 
 
9.3.2
UK
 
 
 
 
 
9.3.2.1
INCREASE IN RESEARCH & DEVELOPMENT ACTIVITIES TO AID GROWTH
 
 
 
9.3.3
GERMANY
 
 
 
 
 
9.3.3.1
GROWING PREVALENCE OF HOSPITAL-ACQUIRED INFECTIONS TO PROPEL MARKET
 
 
 
9.3.4
FRANCE
 
 
 
 
 
9.3.4.1
RISE IN HEALTHCARE BUDGET TO SPUR GROWTH
 
 
 
9.3.5
ITALY
 
 
 
 
 
9.3.5.1
INCREASING NATIONAL HEALTHCARE FUNDING TO FAVOR GROWTH
 
 
 
9.3.6
SPAIN
 
 
 
 
 
9.3.6.1
INCREASING NUMBER OF SURGICAL PROCEDURES TO PROMOTE GROWTH
 
 
 
9.3.7
RUSSIA
 
 
 
 
 
9.3.7.1
ESCALATING DIABETES ISSUE TO DRIVE MARKET
 
 
 
9.3.8
REST OF EUROPE
 
 
 
9.4
ASIA PACIFIC
 
 
 
 
 
9.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
 
 
 
 
9.4.2
CHINA
 
 
 
 
 
9.4.2.1
INCREASING INCIDENCE OF DIABETIC FOOT ULCERS TO ENCOURAGE GROWTH
 
 
 
9.4.3
JAPAN
 
 
 
 
 
9.4.3.1
EVOLVING HEALTHCARE DELIVERY AND INFRASTRUCTURE LANDSCAPE TO FUEL MARKET
 
 
 
9.4.4
INDIA
 
 
 
 
 
9.4.4.1
BOOMING MEDICAL TOURISM TO SPEED UP GROWTH
 
 
 
9.4.5
AUSTRALIA
 
 
 
 
 
9.4.5.1
GROWING FOCUS ON DIABETES MANAGEMENT TO DRIVE MARKET
 
 
 
9.4.6
SOUTH KOREA
 
 
 
 
 
9.4.6.1
INCREASING AWARENESS AND FOCUS ON ADVANCED WOUND CARE THERAPIES TO FACILITATE GROWTH
 
 
 
9.4.7
SINGAPORE
 
 
 
 
 
9.4.7.1
INCREASING HEALTHCARE SPENDING TO SUSTAIN GROWTH
 
 
 
9.4.8
REST OF ASIA PACIFIC
 
 
 
9.5
LATIN AMERICA
 
 
 
 
 
9.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
 
 
 
 
9.5.2
BRAZIL
 
 
 
 
 
9.5.2.1
FREE HEALTHCARE SERVICES TO BOLSTER GROWTH
 
 
 
9.5.3
MEXICO
 
 
 
 
 
9.5.3.1
EXPANDING HOSPITAL INFRASTRUCTURE TO AID GROWTH
 
 
 
9.5.4
REST OF LATIN AMERICA
 
 
 
9.6
MIDDLE EAST & AFRICA
 
 
 
 
 
9.6.1
GROWING DEMAND FOR HEALTHCARE FACILITIES TO DRIVE MARKET
 
 
 
 
9.6.2
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
 
 
10
COMPETITIVE LANDSCAPE
Discover strategic shifts shaping market dominance in negative pressure wound therapy.
 
 
 
173
 
10.1
OVERVIEW
 
 
 
 
10.2
KEY PLAYER STRATEGIES/RIGHT TO WIN, 2024
 
 
 
 
 
10.2.1
OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN NEGATIVE PRESSURE WOUND THERAPY MARKET
 
 
 
10.3
REVENUE ANALYSIS, 2022–2024
 
 
 
 
 
10.4
MARKET SHARE ANALYSIS, 2024
 
 
 
 
 
10.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
 
 
 
 
 
 
10.5.1
STARS
 
 
 
 
10.5.2
EMERGING LEADERS
 
 
 
 
10.5.3
PERVASIVE PLAYERS
 
 
 
 
10.5.4
PARTICIPANTS
 
 
 
 
10.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2024
 
 
 
 
 
10.5.5.1
COMPANY FOOTPRINT
 
 
 
 
10.5.5.2
REGION FOOTPRINT
 
 
 
 
10.5.5.3
PRODUCT TYPE FOOTPRINT
 
 
 
 
10.5.5.4
WOUND TYPE FOOTPRINT
 
 
 
 
10.5.5.5
END-USER FOOTPRINT
 
 
10.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
 
 
 
 
 
 
10.6.1
PROGRESSIVE COMPANIES
 
 
 
 
10.6.2
RESPONSIVE COMPANIES
 
 
 
 
10.6.3
DYNAMIC COMPANIES
 
 
 
 
10.6.4
STARTING BLOCKS
 
 
 
 
10.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
 
 
 
 
 
10.6.5.1
DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
10.6.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
10.7
COMPANY VALUATION AND FINANCIAL METRICS
 
 
 
 
 
10.7.1
COMPANY VALUATION
 
 
 
 
10.7.2
FINANCIAL METRICS
 
 
 
10.8
BRAND/PRODUCT COMPARISON
 
 
 
 
 
10.9
COMPETITIVE SCENARIO
 
 
 
 
 
10.9.1
PRODUCT LAUNCHES AND APPROVALS
 
 
 
 
10.9.2
DEALS
 
 
 
 
10.9.3
EXPANSIONS
 
 
 
 
10.9.4
OTHER DEVELOPMENTS
 
 
11
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
 
 
 
194
 
11.1
KEY PLAYERS
 
 
 
 
 
11.1.1
SOLVENTUM
 
 
 
 
 
11.1.1.1
BUSINESS OVERVIEW
 
 
 
 
11.1.1.2
PRODUCTS OFFERED
 
 
 
 
11.1.1.3
RECENT DEVELOPMENTS
 
 
 
 
11.1.1.4
MNM VIEW
 
 
 
11.1.2
SMITH+NEPHEW
 
 
 
 
11.1.3
CARDINAL HEALTH
 
 
 
 
11.1.4
MÖLNLYCKE AB
 
 
 
 
11.1.5
CONVATEC GROUP PLC
 
 
 
 
11.1.6
PAUL HARTMANN AG
 
 
 
 
11.1.7
AVERY DENNISON CORPORATION
 
 
 
 
11.1.8
BENQ MATERIALS CORPORATION
 
 
 
 
11.1.9
ADVANCED OXYGEN THERAPY INC.
 
 
 
11.2
OTHER PLAYERS
 
 
 
 
 
11.2.1
DOUBLE MEDICAL TECHNOLOGY INC.
 
 
 
 
11.2.2
CARILEX MEDICAL
 
 
 
 
11.2.3
DEROYAL INDUSTRIES, INC.
 
 
 
 
11.2.4
LOHMANN & RAUSCHER GMBH & CO. KG
 
 
 
 
11.2.5
MEDAXIS LLC
 
 
 
 
11.2.6
GENADYNE BIOTECHNOLOGIES, INC.
 
 
 
 
11.2.7
DIRECT HEALTHCARE GROUP
 
 
 
 
11.2.8
ALLEVA MEDICAL
 
 
 
 
11.2.9
CORK MEDICAL, LLC
 
 
 
 
11.2.10
PENSAR MEDICAL
 
 
 
 
11.2.11
HAROMED
 
 
 
 
11.2.12
GUANGZHOU RAINHOME PHARM & TECH CO., LTD.
 
 
 
 
11.2.13
GUARD MEDICAL
 
 
 
 
11.2.14
DATT MEDIPRODUCTS PRIVATE LIMITED
 
 
 
 
11.2.15
KORAZON MEDICAL DEVICES PRIVATE LIMITED
 
 
 
 
11.2.16
TRIAGE MEDITECH PVT. LTD.
 
 
12
APPENDIX
 
 
 
242
 
12.1
DISCUSSION GUIDE
 
 
 
 
12.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
12.3
CUSTOMIZATION OPTIONS
 
 
 
 
12.4
RELATED REPORTS
 
 
 
 
12.5
AUTHOR DETAILS
 
 
 
LIST OF TABLES
 
 
 
 
 
TABLE 1
NEGATIVE PRESSURE WOUND THERAPY MARKET: INCLUSIONS AND EXCLUSIONS
 
 
 
 
TABLE 2
NEGATIVE PRESSURE WOUND THERAPY MARKET: RISK ASSESSMENT
 
 
 
 
TABLE 3
POPULATION AGES 65 AND ABOVE (% OF TOTAL POPULATION), 2023
 
 
 
 
TABLE 4
ROAD ACCIDENT DEMOGRAPHIC, 2022
 
 
 
 
TABLE 5
CHINA: STATES ON DISCHARGE OF PATIENTS WITH TYPE 2 DFU IN DIFFERENT AGE GROUPS, JANUARY 2017–DECEMBER 2023
 
 
 
 
TABLE 6
RISKS ASSOCIATED WITH NEGATIVE PRESSURE WOUND THERAPY DEVICES
 
 
 
 
TABLE 7
STRATEGIC DEVELOPMENTS IN ASIA PACIFIC, 2023–2024
 
 
 
 
TABLE 8
AVERAGE SELLING PRICING TREND OF NEGATIVE PRESSURE WOUND THERAPY PRODUCTS, 2023–2025
 
 
 
 
TABLE 9
AVERAGE SELLING PRICE TREND OF NEGATIVE PRESSURE WOUND THERAPY PRODUCTS, BY KEY PLAYER, 2023–2025
 
 
 
 
TABLE 10
AVERAGE SELLING PRICE TREND OF NEGATIVE PRESSURE WOUND THERAPY PRODUCTS, BY REGION, 2023–2025
 
 
 
 
TABLE 11
NEGATIVE PRESSURE WOUND THERAPY MARKET: ROLE OF COMPANIES IN ECOSYSTEM
 
 
 
 
TABLE 12
NEGATIVE PRESSURE WOUND THERAPY MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2023–2024
 
 
 
 
TABLE 13
IMPORT DATA (HS CODE 901890), BY COUNTRY, 2020–2024 (USD MILLION)
 
 
 
 
TABLE 14
EXPORT DATA (HS CODE 901890), BY COUNTRY, 2020–2024 (USD MILLION)
 
 
 
 
TABLE 15
NEGATIVE PRESSURE WOUND THERAPY MARKET: KEY CONFERENCES AND EVENTS, 2025–2026
 
 
 
 
TABLE 16
TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS IN JAPAN
 
 
 
 
TABLE 17
NORTH AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 18
EUROPE: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 19
ASIA PACIFIC: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 20
LATIN AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 21
REST OF THE WORLD: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 22
NEGATIVE PRESSURE WOUND THERAPY MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
TABLE 23
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF NEGATIVE PRESSURE WOUND THERAPY PRODUCTS (%)
 
 
 
 
TABLE 24
KEY BUYING CRITERIA FOR NEGATIVE PRESSURE WOUND THERAPY PRODUCTS
 
 
 
 
TABLE 25
US ADJUSTED RECIPROCAL TARIFF RATES
 
 
 
 
TABLE 26
NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 27
KEY COMPANIES OFFERING CONVENTIONAL NEGATIVE PRESSURE WOUND THERAPY DEVICES
 
 
 
 
TABLE 28
CONVENTIONAL NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 29
NORTH AMERICA: CONVENTIONAL NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 30
EUROPE: CONVENTIONAL NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 31
ASIA PACIFIC: CONVENTIONAL NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 32
LATIN AMERICA: CONVENTIONAL NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 33
KEY COMPANIES OFFERING SINGLE-USE NEGATIVE PRESSURE WOUND THERAPY DEVICES
 
 
 
 
TABLE 34
SINGLE-USE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 35
NORTH AMERICA: SINGLE-USE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 36
EUROPE: SINGLE-USE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 37
ASIA PACIFIC: SINGLE-USE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 38
LATIN AMERICA: SINGLE-USE NEGATIVE PRESSURE WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 39
KEY COMPANIES OFFERING NEGATIVE PRESSURE WOUND THERAPY ACCESSORIES & CONSUMABLES
 
 
 
 
TABLE 40
NEGATIVE PRESSURE WOUND THERAPY ACCESSORIES & CONSUMABLES MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 41
NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY ACCESSORIES & CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 42
EUROPE: NEGATIVE PRESSURE WOUND THERAPY ACCESSORIES & CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 43
ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY ACCESSORIES & CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 44
LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY ACCESSORIES & CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 45
NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 46
NEGATIVE PRESSURE WOUND THERAPY MARKET FOR BURNS AND SURGICAL & OPEN WOUNDS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 47
NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR BURNS AND SURGICAL & OPEN WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 48
EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR BURNS AND SURGICAL & OPEN WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 49
ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR BURNS AND SURGICAL & OPEN WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 50
LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR BURNS AND SURGICAL & OPEN WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 51
NEGATIVE PRESSURE WOUND THERAPY MARKET FOR PRESSURE ULCERS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 52
NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 53
EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 54
ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 55
LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 56
PREVALENCE OF DIABETES, 2024
 
 
 
 
TABLE 57
NUMBER OF ADULT PATIENTS WITH DIABETIC FOOT ULCERS, BY COUNTRY, 2023–2030 (THOUSANDS)
 
 
 
 
TABLE 58
NEGATIVE PRESSURE WOUND THERAPY MARKET FOR DIABETIC FOOT ULCERS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 59
NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 60
EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 61
ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 62
LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 63
NEGATIVE PRESSURE WOUND THERAPY MARKET FOR VENOUS LEG ULCERS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 64
NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 65
EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 66
ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 67
LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 68
NEGATIVE PRESSURE WOUND THERAPY MARKET FOR TRAUMATIC WOUNDS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 69
NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR TRAUMATIC WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 70
EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR TRAUMATIC WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 71
ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR TRAUMATIC WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 72
LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR TRAUMATIC WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 73
NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 74
HOSPITALS PER CAPITA, BY COUNTRY, 2025
 
 
 
 
TABLE 75
NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOSPITALS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 76
NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 77
EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 78
ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 79
LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 80
NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOME CARE SETTINGS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 81
NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 82
EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 83
ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 84
LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 85
NEGATIVE PRESSURE WOUND THERAPY MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 86
NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 87
EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 88
ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 89
LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 90
NEGATIVE PRESSURE WOUND THERAPY MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 91
NORTH AMERICA: KEY MACROECONOMIC INDICATORS
 
 
 
 
TABLE 92
NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 93
NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 94
NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 95
NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 96
US: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 97
US: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 98
US: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 99
CANADA: ESTIMATED PREVALENCE OF DIABETES, 2023–2024
 
 
 
 
TABLE 100
CANADA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 101
CANADA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 102
CANADA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 103
EUROPE: KEY MACROECONOMIC INDICATORS
 
 
 
 
TABLE 104
EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 105
EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 106
EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 107
EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 108
UK: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 109
UK: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 110
UK: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 111
GERMANY: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 112
GERMANY: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 113
GERMANY: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 114
FRANCE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 115
FRANCE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 116
FRANCE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 117
ITALY: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 118
ITALY: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 119
ITALY: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 120
SPAIN: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 121
SPAIN: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 122
SPAIN: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 123
RUSSIA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 124
RUSSIA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 125
RUSSIA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 126
REST OF EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 127
REST OF EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 128
REST OF EUROPE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 129
ASIA PACIFIC: KEY MACROECONOMIC INDICATORS
 
 
 
 
TABLE 130
ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 131
ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 132
ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 133
ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 134
CHINA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 135
CHINA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 136
CHINA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 137
JAPAN: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 138
JAPAN: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 139
JAPAN: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 140
INDIA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 141
INDIA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 142
INDIA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 143
AUSTRALIA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 144
AUSTRALIA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 145
AUSTRALIA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 146
SOUTH KOREA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 147
SOUTH KOREA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 148
SOUTH KOREA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 149
SINGAPORE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 150
SINGAPORE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 151
SINGAPORE: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 152
REST OF ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 153
REST OF ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 154
REST OF ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 155
LATIN AMERICA: KEY MACROECONOMIC INDICATORS
 
 
 
 
TABLE 156
LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 157
LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 158
LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 159
LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 160
BRAZIL: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 161
BRAZIL: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 162
BRAZIL: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 163
MEXICO: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 164
MEXICO: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 165
MEXICO: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 166
REST OF LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 167
REST OF LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 168
REST OF LATIN AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 169
MIDDLE EAST & AFRICA: KEY MACROECONOMIC INDICATORS
 
 
 
 
TABLE 170
MIDDLE EAST & AFRICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 171
MIDDLE EAST & AFRICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 172
MIDDLE EAST & AFRICA: NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 173
NEGATIVE PRESSURE WOUND THERAPY MARKET: OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 174
NEGATIVE PRESSURE WOUND THERAPY MARKET: DEGREE OF COMPETITION
 
 
 
 
TABLE 175
NEGATIVE PRESSURE WOUND THERAPY MARKET: REGION FOOTPRINT
 
 
 
 
TABLE 176
NEGATIVE PRESSURE WOUND THERAPY MARKET: PRODUCT TYPE FOOTPRINT
 
 
 
 
TABLE 177
NEGATIVE PRESSURE WOUND THERAPY MARKET: WOUND TYPE FOOTPRINT
 
 
 
 
TABLE 178
NEGATIVE PRESSURE WOUND THERAPY MARKET: END-USER FOOTPRINT
 
 
 
 
TABLE 179
NEGATIVE PRESSURE WOUND THERAPY MARKET: DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
TABLE 180
NEGATIVE PRESSURE WOUND THERAPY MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
 
 
TABLE 181
NEGATIVE PRESSURE WOUND THERAPY MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 182
NEGATIVE PRESSURE WOUND THERAPY MARKET: DEALS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 183
NEGATIVE PRESSURE WOUND THERAPY MARKET: EXPANSIONS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 184
NEGATIVE PRESSURE WOUND THERAPY MARKET: OTHER DEVELOPMENTS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 185
SOLVENTUM: COMPANY OVERVIEW
 
 
 
 
TABLE 186
SOLVENTUM: PRODUCTS OFFERED
 
 
 
 
TABLE 187
SOLVENTUM: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 188
SOLVENTUM: OTHER DEVELOPMENTS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 189
SMITH+NEPHEW: COMPANY OVERVIEW
 
 
 
 
TABLE 190
SMITH+NEPHEW: PRODUCTS OFFERED
 
 
 
 
TABLE 191
SMITH+NEPHEW: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 192
SMITH+NEPHEW: DEALS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 193
SMITH+NEPHEW: EXPANSIONS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 194
CARDINAL HEALTH: COMPANY OVERVIEW
 
 
 
 
TABLE 195
CARDINAL HEALTH: PRODUCTS OFFERED
 
 
 
 
TABLE 196
CARDINAL HEALTH: DEALS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 197
CARDINAL HEALTH: EXPANSIONS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 198
MÖLNLYCKE AB: COMPANY OVERVIEW
 
 
 
 
TABLE 199
MÖLNLYCKE AB: PRODUCTS OFFERED
 
 
 
 
TABLE 200
MÖLNLYCKE AB: DEALS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 201
CONVATEC GROUP PLC: COMPANY OVERVIEW
 
 
 
 
TABLE 202
CONVATEC GROUP PLC: PRODUCTS OFFERED
 
 
 
 
TABLE 203
CONVATEC GROUP PLC: DEALS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 204
PAUL HARTMANN AG: COMPANY OVERVIEW
 
 
 
 
TABLE 205
PAUL HARTMANN AG: PRODUCTS OFFERED
 
 
 
 
TABLE 206
PAUL HARTMANN AG: DEALS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 207
AVERY DENNISON CORPORATION: COMPANY OVERVIEW
 
 
 
 
TABLE 208
AVERY DENNISON CORPORATION: PRODUCTS OFFERED
 
 
 
 
TABLE 209
AVERY DENNISON CORPORATION: DEALS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 210
AVERY DENNISON CORPORATION: EXPANSIONS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 211
BENQ MATERIALS CORPORATION: COMPANY OVERVIEW
 
 
 
 
TABLE 212
BENQ MATERIALS CORPORATION: PRODUCTS OFFERED
 
 
 
 
TABLE 213
BENQ MATERIALS CORPORATION: DEALS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 214
BENQ MATERIALS CORPORATION: OTHER DEVELOPMENTS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 215
ADVANCED OXYGEN THERAPY INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 216
ADVANCED OXYGEN THERAPY INC.: PRODUCTS OFFERED
 
 
 
 
TABLE 217
ADVANCED OXYGEN THERAPY INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–MARCH 2025
 
 
 
 
TABLE 218
DOUBLE MEDICAL TECHNOLOGY INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 219
CARILEX MEDICAL: COMPANY OVERVIEW
 
 
 
 
TABLE 220
DEROYAL INDUSTRIES, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 221
LOHMANN & RAUSCHER GMBH & CO. KG: COMPANY OVERVIEW
 
 
 
 
TABLE 222
MEDAXIS LLC: COMPANY OVERVIEW
 
 
 
 
TABLE 223
GENADYNE BIOTECHNOLOGIES, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 224
DIRECT HEALTHCARE GROUP: COMPANY OVERVIEW
 
 
 
 
TABLE 225
ALLEVA MEDICAL: COMPANY OVERVIEW
 
 
 
 
TABLE 226
CORK MEDICAL, LLC: COMPANY OVERVIEW
 
 
 
 
TABLE 227
PENSAR MEDICAL: COMPANY OVERVIEW
 
 
 
 
TABLE 228
HAROMED: COMPANY OVERVIEW
 
 
 
 
TABLE 229
GUANGZHOU RAINHOME PHARM & TECH CO., LTD.: COMPANY OVERVIEW
 
 
 
 
TABLE 230
GUARD MEDICAL: COMPANY OVERVIEW
 
 
 
 
TABLE 231
DATT MEDIPRODUCTS PRIVATE LIMITED: COMPANY OVERVIEW
 
 
 
 
TABLE 232
KORAZON MEDICAL DEVICES PRIVATE LIMITED: COMPANY OVERVIEW
 
 
 
 
TABLE 233
TRIAGE MEDITECH PVT. LTD.: COMPANY OVERVIEW
 
 
 
 
LIST OF FIGURES
 
 
 
 
 
FIGURE 1
NEGATIVE PRESSURE WOUND THERAPY MARKET SEGMENTATION AND REGIONAL SCOPE
 
 
 
 
FIGURE 2
NEGATIVE PRESSURE WOUND THERAPY MARKET: RESEARCH DESIGN
 
 
 
 
FIGURE 3
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
 
 
 
 
FIGURE 4
BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
 
 
 
 
FIGURE 5
CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
 
 
 
 
FIGURE 6
NEGATIVE PRESSURE WOUND THERAPY MARKET: TOP-DOWN APPROACH
 
 
 
 
FIGURE 7
DATA TRIANGULATION METHODOLOGY
 
 
 
 
FIGURE 8
NEGATIVE PRESSURE WOUND THERAPY MARKET, BY PRODUCT TYPE, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 9
NEGATIVE PRESSURE WOUND THERAPY MARKET, BY WOUND TYPE, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 10
NEGATIVE PRESSURE WOUND THERAPY MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 11
GEOGRAPHICAL SNAPSHOT OF NEGATIVE PRESSURE WOUND THERAPY MARKET, 2025–2030
 
 
 
 
FIGURE 12
INCREASING PREVALENCE OF DIABETES TO DRIVE MARKET
 
 
 
 
FIGURE 13
HOSPITALS SEGMENT AND CHINA LED ASIA PACIFIC MARKET IN 2024
 
 
 
 
FIGURE 14
CHINA TO RECORD HIGHEST GROWTH RATE FROM 2025 TO 2030
 
 
 
 
FIGURE 15
ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
 
 
 
 
FIGURE 16
NEGATIVE PRESSURE WOUND THERAPY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
 
 
 
 
FIGURE 17
NEGATIVE PRESSURE WOUND THERAPY MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS
 
 
 
 
FIGURE 18
NEGATIVE PRESSURE WOUND THERAPY MARKET: VALUE CHAIN ANALYSIS
 
 
 
 
FIGURE 19
NEGATIVE PRESSURE WOUND THERAPY MARKET: SUPPLY CHAIN ANALYSIS
 
 
 
 
FIGURE 20
NEGATIVE PRESSURE WOUND THERAPY MARKET: ECOSYSTEM ANALYSIS
 
 
 
 
FIGURE 21
NEGATIVE PRESSURE WOUND THERAPY MARKET: INVESTMENT AND FUNDING SCENARIO, 2019–2025
 
 
 
 
FIGURE 22
NEGATIVE PRESSURE WOUND THERAPY MARKET: PATENT ANALYSIS, JANUARY 2015–DECEMBER 2024
 
 
 
 
FIGURE 23
NEGATIVE PRESSURE WOUND THERAPY MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
FIGURE 24
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF NEGATIVE PRESSURE WOUND THERAPY PRODUCTS
 
 
 
 
FIGURE 25
KEY BUYING CRITERIA FOR NEGATIVE PRESSURE WOUND THERAPY PRODUCTS
 
 
 
 
FIGURE 26
AI USE CASES
 
 
 
 
FIGURE 27
NORTH AMERICA: NEGATIVE PRESSURE WOUND THERAPY MARKET SNAPSHOT
 
 
 
 
FIGURE 28
ASIA PACIFIC: NEGATIVE PRESSURE WOUND THERAPY MARKET SNAPSHOT
 
 
 
 
FIGURE 29
NEGATIVE PRESSURE WOUND THERAPY MARKET: REVENUE ANALYSIS OF KEY PLAYERS, 2022–2024
 
 
 
 
FIGURE 30
NEGATIVE PRESSURE WOUND THERAPY MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024
 
 
 
 
FIGURE 31
RANKING OF KEY PLAYERS IN NEGATIVE PRESSURE WOUND THERAPY MARKET, 2024
 
 
 
 
FIGURE 32
NEGATIVE PRESSURE WOUND THERAPY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
 
 
 
 
FIGURE 33
NEGATIVE PRESSURE WOUND THERAPY MARKET: COMPANY FOOTPRINT
 
 
 
 
FIGURE 34
NEGATIVE PRESSURE WOUND THERAPY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
 
 
 
 
FIGURE 35
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
 
 
 
 
FIGURE 36
EV/EBITDA OF KEY VENDORS
 
 
 
 
FIGURE 37
NEGATIVE PRESSURE WOUND THERAPY MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
 
 
 
 
FIGURE 38
SOLVENTUM: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 39
SMITH+NEPHEW: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 40
CARDINAL HEALTH: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 41
MÖLNLYCKE AB: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 42
CONVATEC GROUP PLC: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 43
PAUL HARTMANN AG: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 44
AVERY DENNISON CORPORATION: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 45
BENQ MATERIALS CORPORATION: COMPANY SNAPSHOT (2023)
 
 
 
 
FIGURE 46
ADVANCED OXYGEN THERAPY INC.: COMPANY SNAPSHOT (2024)
 
 
 
 

Methodology

The study involved major activities in estimating the current market size for the negative pressure wound therapy market. Exhaustive secondary research was done to collect information on the negative pressure wound therapy industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the negative pressure wound therapy market.

The four steps involved in estimating the market size are:

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), , Global Burden of Disease Study, and Centers for Medicare and Medicaid Services (CMS) were referred to identify and collect information for the global negative pressure wound therapy market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the negative pressure wound therapy market. The primary sources from the demand side include pharmaceutical companies, biotechnology companies, CROs, pharmacies, medical device companies, and research academics and universities. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.

The following is a breakdown of the primary respondents:

Negative Pressure Wound Therapy Market

Note 1: Other designations include sales managers, marketing managers, and product managers.

Note 2: Companies are classified into tiers based on their total revenues. As of 2024, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global negative pressure wound therapy market. All the major service providers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players. The global negative pressure wound therapy market was split into various segments and sub-segments based on:

  • List of major players operating in the products market at the regional and/or country level
  • Product mapping of negative pressure wound therapy providers at the regional and/or country level
  • Mapping of annual revenue generated by listed major players from negative pressure wound therapy (or the nearest reported business unit/product category)
  • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
  • Summation of the market value of all segments/subsegments to arrive at the global negative pressure wound therapy market

The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

The research methodology used to estimate the market size includes the following:

Negative Pressure Wound Therapy Market

Data Triangulation

After arriving at the overall market size by applying the process mentioned above, the total market was split into several segments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Negative pressure wound therapy is a treatment that pulls fluid and bacteria out of a wound to help it heal better. Some healthcare providers call it vacuum-assisted therapy. It works by creating suction. A provider can use this treatment to heal soft tissue on many different parts of your body.

Stakeholders

  • NPWT Device Manufacturers
  • Hospitals and ASCs
  • Research and Consulting Firms
  • Distributors of NPWT Devices
  • Contract Manufacturers of NPWT Devices
  • Venture Capitalists and Investors
  • Government Wound Care Organizations

Report Objectives

  • To define, describe, segment, and forecast the global negative pressure wound therapy market by product type, wound type, end user, and region
  • To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall negative pressure wound therapy market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market segments with respect to five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product excellence
  • To study the impact of AI/Gen AI on the market, along with the macroeconomic outlook for each region

 

Frequently Asked Questions(FAQ)

Which are the top industry players in the Negative Pressure Wound Therapy market?

The key players in this market are Solventum (US), Smith+Nephew (UK), Cardinal Health (US), Mölnlycke AB (Sweden), Convatec Group PLC (UK), PAUL HARTMANN AG (Germany), Avery Dennison Corporation (US), BenQ Materials Corporation (Taiwan), Double Medical Technology Inc. (China), and Carilex Medical (Taiwan).

What are some of the major drivers for this market?

The market is driven by the increasing prevalence of diabetes, a rising geriatric population, a rise in burn and trauma incidents, and favorable government initiatives.

Which products have been included in the global negative pressure wound therapy market?

The product segments include conventional NPWT devices, single-use NPWT devices, and NPWT accessories & consumables. In 2024, conventional NPWT devices held the largest market share.

Which end users have been included in the global negative pressure wound therapy market?

End-user segments include Hospitals, Home Care Settings, and Other End Users.

Which region is lucrative for the global negative pressure wound therapy market?

The Asia Pacific region is expected to witness the highest CAGR during the forecast period due to an aging population, rising healthcare costs, and a growing incidence of chronic wounds.

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Negative Pressure Wound Therapy Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Negative Pressure Wound Therapy Market

DMCA.com Protection Status